The Kentucky SBIR-STTR Matching Funds Program is funded by the Cabinet for Economic Development, CED, Office of Commercialization and Innovation, OCI. The Matching Funds Program provides Matching Funds up to $150,000 for Phase I and up to $500,000 for Phase II (up to two years). These Matching Funds are to be used for new and additional work tasks that are complementary to your existing Federal SBIR-STTR Award. Companies from Kentucky and those willing to move to Kentucky can apply and receive Matching Funds Grant Awards. The distribution of funds for out-of-state applicants; however, will be contingent upon meeting all the requirements within the guidelines, including relocating your business to the state of Kentucky within 90 days of the date on the Kentucky SBIR-STTR Matching Funds Grant Agreement. Other stipulations found in the guidelines include that a recipient of the Kentucky Matching Funds Award is required to maintain their Kentucky based status for 5 years after receipt of the final disbursement of funds and at least 51% of the company’s property and payroll must be in Kentucky. And, at least 51% of the Matching Funds grant amount must be spent in Kentucky.
Learn more and see list of awardees here.
IF University: Think Quick: Try Improv
IF University: The AWESOME School
GSE 2014 Summer Program
Kentucky’s Governor’s School for Entrepreneurs (GSE) is now accepting applications from Kentucky high school students for its 2014 summer program. Application Deadline Extended!
The application deadline has been extended to February 7, 2014. Application details are available online at http://gse.kstc.com.
Applications will be accepted between January 1, 2014 and January 31, 2014. The deadline to submit an application is 4:00 p.m. Eastern Time on Jan. 31, 2014. Read More
KSTC is an entrepreneurial company dedicated to enhancing the capacity of people, companies and organizations to develop and apply science and technology and compete responsibly in the global marketplace.
Copyright © 2003 - 2012 KSTCSite Powered by Emergix